Enorama Pharma AB (ERMA)
XSTO XSTO Primary Summary
Enorama Pharma AB (ERMA) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Enorama Pharma AB ever had a stock split?
Enorama Pharma AB Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Daniel Schroder CEO | XSTO Exchange | SE0008216329 ISIN |
| Sweden Country | 5 Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
Enorama Pharma AB (publ) is a prominent pharmaceutical company that was established in 2006. Situated in Malmö, Sweden, this firm specializes in the production and distribution of medical chewing gum and a diverse range of nicotine products. With its innovative approach, Enorama Pharma AB positions itself as a leader in offering alternative pharmacological solutions, focusing on consumer-friendly formats. Their mission extends to developing and commercializing medical cannabis products, reflecting their commitment to addressing a broad spectrum of therapeutic needs.
Products and Services
- Medical Chewing Gum:
This product leverages the unique delivery system of chewing gum to administer medication. It is designed for users seeking an easy-to-use, discreet, and effective way to consume their medicine. The medical chewing gum line targets various therapeutic areas, providing not only a novel mode of delivery but also enhancing patient compliance.
- Nicotine Products:
Enorama Pharma AB produces a vast array of nicotine products intended for smokers looking to quit or reduce their smoking habits. These products include nicotine chewing gum, offering a less harmful alternative to cigarettes. By focusing on nicotine replacement therapies, the company aids individuals in their journey towards smoking cessation.
- Nicotine Pouches:
As a smokeless and spit-free alternative, nicotine pouches represent a modern approach to nicotine satisfaction without the use of tobacco. These discreet, small pouches are designed to be placed under the lip, providing a convenient and less intrusive method for nicotine intake. This innovative solution caters to users seeking to avoid the social and health impacts of smoking and dipping tobacco.
- Medical Cannabis Products:
Recognizing the therapeutic potential of cannabis, Enorama Pharma AB has ventured into the medical cannabis market. Their products include formulations designed to meet specific medical indications, addressing a range of conditions such as chronic pain, epilepsy, and multiple sclerosis. With a commitment to research and development, the company ensures their cannabis products meet high quality and safety standards, offering patients reliable and effective treatment options.
